Neutralizing Endogenous IL-6 Renders Mast Cells of the MCT Type from Lung, but Not the MCTC Type from Skin and Lung, Susceptible to Human Recombinant IL-4-Induced Apoptosis

Journal of Immunology

Volumn 172, Issue 1, 2004, Pages 593-600

  Oskeritzian, Carole A ^a   Zhao, Wei ^a   Pozez, Andrea L ^a   Cohen, Neri M ^a   Grimes, Margaret ^b   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 4;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FETUS LIVER; HUMAN; HUMAN CELL; LUNG; MAST CELL; PHENOTYPE; PRIORITY JOURNAL; SKIN; UMBILICAL CORD BLOOD;

EID: 0347994942     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.1.593     Document Type: Article

References (66)

1. Oskeritzian, C. A., Z. Wang, J. P. Kochan, M. Grimes, Z. Du, H. W. Chang, S. Grant, and L. B. Schwartz. 1999. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J. Immunol. 163:5105.
2. Gooch, J. L., A. V. Lee, and D. Yee. 1998. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res. 58:4199.
3. Manabe, A., E. Coustan-Smith, M. Kumagai, F. G. Behm, S. C. Raimondi, C. H. Pui, and D. Campana. 1994. Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood 83:1731.
4. Mangan, D. F., B. Robertson, and S. M. Wahl. 1992. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J. Immunol. 148:1812.
5. Wedi, B., U. Raap, H. Lewrick, and A. Kapp. 1998. IL-4-induced apoptosis in peripheral blood eosinophils. J. Allergy Clin. Immunol. 102:1013.
6. Chauhan, D., S. Kharbanda, A. Ogata, M. Urashima, G. Teoh, M. Robertson, D. W. Kufe, and K. C. Anderson. 1997. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 89:227.
7. Lichtenstein, A., Y. Tu, C. Fady, R. Vescio, and J. Berenson. 1995. Interleukin-6 inhibits apoptosis of malignant plasma cells. Cell. Immunol. 162:248.
8. Lotem, J., and L. Sachs. 1992. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80:1750.
9. Umegaki, H., K. Yamada, M. Naito, T. Kameyama, A. Iguchi, and T. Nabeshima. 1996. Protective effect of interleukin-6 against the death of PC12 cells caused by serum deprivation or by the addition of a calcium ionophore. Biochem. Pharmacol. 52:911.
10. Borsellino, N., A. Belldegrun, and B. Bonavida. 1995. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res. 55:4633.
11. Adkins, B., K. Chun, K. Hamilton, and M. Nassiri. 1996. Naive murine neonatal T cells undergo apoptosis in response to primary stimulation. J. Immunol. 157:1343.
12. Ward, N. S., A. B. Waxman, R. J. Homer, L. L. Mantell, O. Einarsson, Y. Du, and J. A. Elias. 2000. Interleukin-6-induced protection in hyperoxic acute lung injury. Am. J. Respir. Cell Mol. Biol. 22:535.
13. Dedoussis. G. V., A. Mouzaki, M. Theodoropoulou, P. Menounos, M. C. Kyrtsonis, A. Karameris, and A. Maniatis. 1999. Endogenous interleukin 6 conveys resistance to cis-diamminedichloroplatinum-mediated apoptosis of the K562 human leukemic cell line. Exp. Cell Res. 249:269.
14. Chauhan, D., P. Pandey, T. Hideshima, S. Treon, N. Raje, F. Davies, Y. Shima, Y. T. Tai, S. Rosen, S. Avraham, S. Kharbanda, and K. C. Anderson. 2000. SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells. J. Biol. Chem. 275:27845.
15. Puthier, D., S. Derenne, S. Barille, P. Moreau, J. L. Harousseau, R. Bataille, and M. Amiot. 1999. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells. Br. J. Haematol. 107:392.
16. Chung, T. D., J. J. Yu, T. A. Kong, M. T. Spiotto, and J. M. Lin. 2000. Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines. Prostate 42:1.
17. Chen, R. H., M. C. Chang, Y. H. Su, Y. T. Tsai, and M. L. Kuo. 1999. Interleukin-6 inhibits transforming growth factor-β-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem. 274:23013.
18. Xia, H. Z., Z. M. Du, S. Craig, G. Klisch, N. Noben-Trauth, J. P. Kochan, T. H. Huff, A. M. Irani, and L. B. Schwartz. 1997. Effect of recombinant human IL-4 on tryptase, chymase, and Fcε receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J. Immunol. 159:2911.
19. Toru, H., C. Ra, S. Nonoyama, K. Suzuki, J. Yata, and T. Nakahata. 1996. Induction of the high-affinity IgE receptor (FcεR1) on human mast cells by IL-4. Int. Immunol. 8:1367.
20. Sillaber, C., H. Strobl, D. Bevec, L. K. Ashman, J. H. Butterfield, K. Lechner, D. Maurer, P. Bettelheim, and P. Valent. 1991. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J. Immunol. 147:4224.
21. Bischoff, S. C., G. Sellge, A. Lorentz, W. Sebald, R. Raab, and M. P. Manns. 1999. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc. Natl. Acad. Sci. USA 96:8080.
22. Sillaber, C., W. R. Sperr, H. Agis, E. Spanblöchl, K. Lechner, and P. Valent. 1994. Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4. Int. Arch. Allergy Immunol. 105:264.
23. + cord blood cells. Blood 94:496.
24. Nilsson, G., U. Miettinen, T. Ishizaka, L. K. Ashman, A. M. Irani, and L. B. Schwartz. 1994. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 84:1519.
25. Yanagida, M., H. Fukamachi. K. Ohgami, T. Kuwaki, H. Ishii, H. Uzumaki, K. Amano, T. Tokiwa, H. Mitsui, H. Saito, et al. 1995. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86:3705.
26. Toru, H., M. Eguchi, R. Matsumoto, M. Yanagida, J. Yata, and T. Nakahata. 1998. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 91:187.
27. Toru, H., T. Kinashi, C. Ra, S. Nonoyama, J. Yata, and T. Nakahata. 1997. Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood 89:3296.
28. Du, Z. M., Y. L. Li, H. Z. Xia, A. M. Irani, and L. B. Schwartz. 1997. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells. J. Immunol. 159:838.
29. Xia, H.-Z., C. L. Kepley, K. Sakai, J. Chelliah, A.-M. A. Irani, and L. B. Schwartz. 1995. Quantitation of tryptase, chymase, FcεRIα, and FcεRIγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J. Immunol. 154:5472.
30. Kambe, N., M. Kambe, J. P. Kochan, and L. B. Schwartz. 2001. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood 97:2045.
31. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J. Histochem. Cytochem. 37:1509.
32. Kambe, M., N. Kambe, C. A. Oskeritzian, N. Schechter, and L. B. Schwartz. 2001. IL-6 attenuates apoptosis, while neither IL-6 nor IL-10 affect the numbers or protease phenotype of fetal liver-derived human mast cells. Clin. Exp. Allergy 31:1077.
33. Irani, A. A., N. M. Schechter, S. S. Craig, G. DeBlois, and L. B. Schwartz. 1986. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83:4464.
34. TC type of human mast cell. J. Immunol. 145:2652.
35. TC cells. J. Immunol. 147:247.
36. Bradding, P., I. H. Feather, S. Wilson, P. G. Bardin, C. H. Heusser, S. T. Holgate, and P. H. Howarth. 1993. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: the mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J. Immunol. 151:3853.
37. Bradding, P., I. H. Feather, S. Wilson, S. T. Holgate, and P. H. Howarth. 1995. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am. J. Respir. Crit. Care Med. 151:1900.
38. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471.
39. MacLeod, J. D., D. F. Anderson, S. M. Baddeley, S. T. Holgate, J. I. McGill, and W. R. Roche. 1997. Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva. Clin. Exp. Allergy 27:1328.
40. Lorentz, A., S. Schwengberg, G. Sellge, R. P. Manns, and S. C. Bischoff. 2000. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J. Immunol. 164:43.
41. Bradding, P., Y. Okayama, P. H. Howarth, M. K. Church, and S. T. Holgate. 1995. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155:297.
42. Krüger-Krasagakes, S., A. M. Möller, G. Kolde, U. Lippert, M. Weber, and B. M. Henz. 1996. Production of inteuleukin-6 by human mast cells and basophilic cells. J. Invest. Dermatol. 106:75.
43. Nilsson, G., V. Svensson, and K. Nilsson. 1995. Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1. Scand. J. Immunol. 42:76.
44. Sillaber, C., D. Bevec, J. H. Butterfield, C. Heppner, R. Valenta, O. Scheiner, D. Kraft, K. Lechner, P. Bettelheim, and P. Valent. 1993. Tumor necrosis factor α and interleukin-1β mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Exp. Hematol. 21:1271.
45. Barata, L. T., S. Ying, Q. Meng, J. Barkans, K. Rajakulasingam, S. R. Durham, and A. B. Kay. 1998. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Allergy Clin. Immunol. 101:222.
46. Bradding, P., I. H. Feather, P. H. Howarth, R. Mueller, J. A. Roberts, K. Britten, J. P. A. Bews, T. C. Hunt, Y. Okayama, C. H. Heusser, et al. 1992. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176:1381.
47. Horsmanheimo, L., I. T. Harvima, A. Järvikallio, R. J. Harvima, A. Naukkarinen, and M. Horsmanheimo. 1994. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br. J. Dermatol. 131:348.
48. Pawankar, R., M. Okuda, H. Yssel, K. Okumura, and C. Ra. 1997. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99:1492.
49. Ying, S., S. R. Durham, M. R. Jacobson, S. Rak, K. Masuyama, O. Lowhagen, A. B. Kay, and Q. A. Hamid. 1994. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 82:200.
50. Okayama, Y., C. Petit-Frére, O. Kassel, A. Semper, D. Quint, M. J. Tunon-de-Lara, P. Bradding, S. T. Holgate, and M. K. Church. 1995. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J. Immunol. 155:1796.
51. Okayama, Y., A. Semper, S. T. Holgate, and M. K. Church. 1995. Multiple cytokine mRNA expression in human mast cells stimulated via FcεRI. Int. Arch. Allergy Immunol. 107:158.
52. Ying, S., S. R. Durham, C. J. Corrigan, Q. Hamid, and A. B. Kay. 1995. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477.
53. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 158:3539.
54. Ligumsky, M., V. Kuperstein, H. Nechushtan, Z. C. Zhang, and E. Razin. 1997. Analysis of cytokine profile in human colonic mucosal FcεRI-positive cells by single cell PCR: inhibition of IL-3 expression in steroid-treated IBD patients. FEBS Lett. 413:436.
55. Toru, H., R. Pawankar, C. Ra, J. Yata, and T. Nakahata. 1998. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J. Allergy Clin. Immunol. 102:491.
56. Wery-Zennaro, S., J. L. Zugaza, M. Letourneur, J. Bertoglio, and J. Pierre. 2000. IL-4 regulation of IL-6 production involves Rac/Cdc42- and p38 MAPK-dependent pathways in keratinocytes. Oncogene 19:1596.
57. Howells, G., P. Pham, D. Taylor, B. Foxwell, and M. Feldmann. 1991. Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-γ. Eur. J. Immunol. 21:97.
58. Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, G. W. Canonica, C. Jasmin, and B. Azzarone. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts: implication in asthma. J. Clin. Invest. 101:2129.
59. Striz, I., T. Mio, Y. Adachi, D. J. Romberger, and S. I. Rennard. 1999. Th2-type cytokines modulate IL-6 release by human bronchial epithelial cells. Immunol. Lett. 70:83.
60. Van Der, M. A., C. Squiban, P. Gourmelon, H. Lafont, and M. H. Gaugler. 1999. Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells. Cytokine 11:831.
61. Denizot, Y., A. Besse, S. Raher, R. Nachat, F. Trimoreau, V. Praloran, and A. Godard. 1999. Interleukin-4 (IL-4), but not IL-10, regulates the synthesis of IL-6, IL-8 and leukemia inhibitory factor by human bone marrow stromal cells. Biochim. Biophys. Acta 1449:83.
62. Lindstedt, K. A., Y. Wang, N. Shiota, J. Saarinen, M. Hyytiainen, J. O. Kokkonen, J. Keski-Oja, and P. T. Kovanen. 2001. Activation of paracrine TGF-β1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J. 15:1377.
63. De Paulis, A., G. Minopoli, F. Dal Piaz, P. Pucci, T. Russo, and G. Marone. 1999. Novel autocrine and paracrine loops of the stem cell factor/chymase network. Int. Arch. Allergy Immunol. 118:422.
64. TC in vernal conjunctivitis and giant papillary conjunctivitis. J. Allergy Clin. Immunol. 86:34.
65. Irani, A.-M. A., H. A. Sampson, and L. B. Schwartz. 1989. Mast cells in atopic dermatitis. Allergy 44(Suppl. 9):31.
66. TC subset with matrix turnover and clinical progression. Arthritis Rheum. 40:479.